[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MAPS: On Psychedelics in Our Time



Hi, to all.
The recent postings by prospective graduate students have got me thinking.  I once read an interview with James Watson, the co-discoverer of DNA, who said that he tries to teach his grad students both what they can do with the existing equipment, and what would be worth going after if new equipment were to provide the opportunity.  Here are some thoughts of the latter sort.
In this alarmingly warmest of Toronto winters, following a visit to our city zoo, it occurred to me that our species can have no long-term future unless we learn to mass-market effective psychotherapy as, in the 19th century, public education was made social policy internationally.  We have well-intentioned, knowledgeable people in government throughout the Western democracies (and lots of reprobates too, of course), but little comes of it because the mental health is not there.  However, as long as psychotherapy requires as much time and work as it does, and is as chancy in its results, psychotherapy will remain the elitist phenomenon that it has always been, and the future of our species must be bleak.
Among possible ways to mass-market psychotherapy, a psychedelic assisted psychotherapy, that is, a psycholytic therapy, is, to my thought, the most promising possibility on the horizon.  But the possibility needs a lot of work, because existing techniques are still very unreliable.  Our best people are still trying to demonstrate that psychedelics can facilitate psychotherapy; no one is trying to argue that a psychedelic-assisted psychotherapy is by far and away the fastest, most reliable and/or most through of psychotherapies--as would be needed for a mass market to occur.
I also suggest that a psychedelic-assisted psychotherapy is the best use for psychedelics that I can currently imagine.  This realization represents a significant change of priorities for me personally.  For thirty plus years I have thought of psychedelics as religious sacraments that happen to have psychotherapeutic use as an occasional side-effect.  This bias was adopted from my first exposure to psychedelics in the context of the mass social movement of the late 60s and early 70s.  Wasson, Hofmann, and Ruck's book on the Eleusinian Mysteries also made it clear to me that psychedelics have also been used historically in the context of religious initiation practices.  In both sociological contexts--religious renewal movements, and individual initiation rites--psychedelics have historically had limited appeal.  The problem of bad trips outweighs the benefits of good ones for most people, and only a few remain dedicated to the sacrament.
On the other hand, the concept of the unconscious was known in antiquity and widely accepted among Western intellectuals from the Renaissance onward.  What Freud did (and Freud, according to his son Martin, was a secret hunter of wild mushrooms, including psychoactive varieties!) was not to discover the unconscious, but rather to develop a psychotherapeutic technique that made it necessary to work with the concept.  Similarly, religious approaches to the use of psychedelics have been around since time immemorial--perhaps prior to the origin of our species--but we have as yet no technique for using psychedelics whose value is sufficient to win a mass market.  I venture to hope that the psychotherapeutic use of psychedelics has a potential for mass appeal, as the religious use historically has not.
And it is mass therapy, and not mass religion, that our species can no longer afford to do without.
What needs to be developed, I speculate, is a form of psychedelic-assisted psychotherapy that is sufficiently reliable in its production of therapeutic change to command a mass market share.  Cut good psychotherapy down from 7 years to 2, and increase its reliability dramatically (like doubling or tripling the rate of success), and there is a market out there. Potent marijuana, rather than less socially acceptable substances, might be the most marketable way to go.  If such a psychotherapy promotes an ethical (including ecological) responsibility, it will be "good enough" to do the socio-cultural job that needs doing, whether it is explicitly sacramental or not.  The sacramental element could be left as an individual option.
The possibility of using psychedelics as a total program of psychotherapy--that is, "psychedelic psychotherapy" as distinct from "psycholytic" or psychedelic-assisted verbal psychotherapy--has been explored and found too hit-and-miss for marketting success.  It is a variant of the religious initiation model of psychedelic use, with all its limitations.
Here then is work for specialists in the psychology of psychedelics:  developing a clinical technique that maximizes the therapeutic utility of the drugs.
Best wishes,
Dan Merkur